12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Amyvid florbetapir regulatory update

The Centers for Medicare & Medicaid Services issued a proposed decision memo concluding that there is insufficient evidence that beta amyloid PET imaging improves health outcomes in Medicare patients with dementia or neurodegenerative disease. However, the agency recommended covering 1 scan per patient through coverage with evidence development (CED) because there is sufficient...

Read the full 263 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >